Videos

John Bender on Norwich’s New Focus

John Bender on Norwich’s New Focus

John Bender, vice president of commercial operations, on the company’s current focus.

By Kristin Brooks04.15.14
Suggested For You
Softweb Solutions Softweb Solutions
Akebia Therapeutics Names CMO Akebia Therapeutics Names CMO
Tekni-Plex Acquires BrunaSeals Tekni-Plex Acquires BrunaSeals
Worldwide Clinical Trials Appoints Clinical Ops VP Worldwide Clinical Trials Appoints Clinical Ops VP
Pharma Tech Industries Names New VP of Business Development Pharma Tech Industries Names New VP of Business Development
Nektar and Takeda in Research Collaboration Nektar and Takeda in Research Collaboration
Sartorius Partners with Nova Biomedical Sartorius Partners with Nova Biomedical
Cambrex Invests to Increase Pilot Scale API Capacity Cambrex Invests to Increase Pilot Scale API Capacity
Why Data Drives Drug Insights After Market Why Data Drives Drug Insights After Market
Solid Dosage Manufacturing Trends Solid Dosage Manufacturing Trends
Norwich Refines Business Strategy Norwich Refines Business Strategy
Solid Dosage Outsourcing Trends Solid Dosage Outsourcing Trends
Norwich Pharmaceuticals Norwich Pharmaceuticals' Business Surges In Second Half of 2013
Terry Novak Discusses New, Expanded Capabilities Terry Novak Discusses New, Expanded Capabilities
Norwich Strengthens Development Expertise Norwich Strengthens Development Expertise

Related Buyers Guide Companies

    Loading, Please Wait..